Metallodrug Profiling against SARS-CoV-2 Target Proteins Identifies Highly Potent Inhibitors of the S/ACE2 interaction and the Papain-like Protease PLpro
© 2021 The Authors. Chemistry - A European Journal published by Wiley-VCH GmbH..
The global spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has called for an urgent need for dedicated antiviral therapeutics. Metal complexes are commonly underrepresented in compound libraries that are used for screening in drug discovery campaigns, however, there is growing evidence for their role in medicinal chemistry. Based on previous results, we have selected more than 100 structurally diverse metal complexes for profiling as inhibitors of two relevant SARS-CoV-2 replication mechanisms, namely the interaction of the spike (S) protein with the ACE2 receptor and the papain-like protease PLpro . In addition to many well-established types of mononuclear experimental metallodrugs, the pool of compounds tested was extended to approved metal-based therapeutics such as silver sulfadiazine and thiomersal, as well as polyoxometalates (POMs). Among the mononuclear metal complexes, only a small number of active inhibitors of the S/ACE2 interaction was identified, with titanocene dichloride as the only strong inhibitor. However, among the gold and silver containing complexes many turned out to be very potent inhibitors of PLpro activity. Highly promising activity against both targets was noted for many POMs. Selected complexes were evaluated in antiviral SARS-CoV-2 assays confirming activity for gold complexes with N-heterocyclic carbene (NHC) or dithiocarbamato ligands, a silver NHC complex, titanocene dichloride as well as a POM compound. These studies might provide starting points for the design of metal-based SARS-CoV-2 antiviral agents.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:27 |
---|---|
Enthalten in: |
Chemistry (Weinheim an der Bergstrasse, Germany) - 27(2021), 71 vom: 20. Dez., Seite 17928-17940 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Gil-Moles, Maria [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 21.12.2021 Date Revised 16.02.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1002/chem.202103258 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM332528723 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM332528723 | ||
003 | DE-627 | ||
005 | 20240216232150.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/chem.202103258 |2 doi | |
028 | 5 | 2 | |a pubmed24n1295.xml |
035 | |a (DE-627)NLM332528723 | ||
035 | |a (NLM)34714566 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Gil-Moles, Maria |e verfasserin |4 aut | |
245 | 1 | 0 | |a Metallodrug Profiling against SARS-CoV-2 Target Proteins Identifies Highly Potent Inhibitors of the S/ACE2 interaction and the Papain-like Protease PLpro |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 21.12.2021 | ||
500 | |a Date Revised 16.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2021 The Authors. Chemistry - A European Journal published by Wiley-VCH GmbH. | ||
520 | |a The global spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has called for an urgent need for dedicated antiviral therapeutics. Metal complexes are commonly underrepresented in compound libraries that are used for screening in drug discovery campaigns, however, there is growing evidence for their role in medicinal chemistry. Based on previous results, we have selected more than 100 structurally diverse metal complexes for profiling as inhibitors of two relevant SARS-CoV-2 replication mechanisms, namely the interaction of the spike (S) protein with the ACE2 receptor and the papain-like protease PLpro . In addition to many well-established types of mononuclear experimental metallodrugs, the pool of compounds tested was extended to approved metal-based therapeutics such as silver sulfadiazine and thiomersal, as well as polyoxometalates (POMs). Among the mononuclear metal complexes, only a small number of active inhibitors of the S/ACE2 interaction was identified, with titanocene dichloride as the only strong inhibitor. However, among the gold and silver containing complexes many turned out to be very potent inhibitors of PLpro activity. Highly promising activity against both targets was noted for many POMs. Selected complexes were evaluated in antiviral SARS-CoV-2 assays confirming activity for gold complexes with N-heterocyclic carbene (NHC) or dithiocarbamato ligands, a silver NHC complex, titanocene dichloride as well as a POM compound. These studies might provide starting points for the design of metal-based SARS-CoV-2 antiviral agents | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a PLpro | |
650 | 4 | |a SARS-CoV-2 | |
650 | 4 | |a gold, metallodrugs | |
650 | 4 | |a polyoxometalates | |
650 | 4 | |a silver | |
650 | 4 | |a spike protein | |
650 | 4 | |a titanocene | |
650 | 7 | |a Antiviral Agents |2 NLM | |
650 | 7 | |a Spike Glycoprotein, Coronavirus |2 NLM | |
650 | 7 | |a spike protein, SARS-CoV-2 |2 NLM | |
650 | 7 | |a Angiotensin-Converting Enzyme 2 |2 NLM | |
650 | 7 | |a EC 3.4.17.23 |2 NLM | |
650 | 7 | |a Coronavirus Papain-Like Proteases |2 NLM | |
650 | 7 | |a EC 3.4.22.2 |2 NLM | |
650 | 7 | |a papain-like protease, SARS-CoV-2 |2 NLM | |
650 | 7 | |a EC 3.4.22.2 |2 NLM | |
700 | 1 | |a Türck, Sebastian |e verfasserin |4 aut | |
700 | 1 | |a Basu, Uttara |e verfasserin |4 aut | |
700 | 1 | |a Pettenuzzo, Andrea |e verfasserin |4 aut | |
700 | 1 | |a Bhattacharya, Saurav |e verfasserin |4 aut | |
700 | 1 | |a Rajan, Ananthu |e verfasserin |4 aut | |
700 | 1 | |a Ma, Xiang |e verfasserin |4 aut | |
700 | 1 | |a Büssing, Rolf |e verfasserin |4 aut | |
700 | 1 | |a Wölker, Jessica |e verfasserin |4 aut | |
700 | 1 | |a Burmeister, Hilke |e verfasserin |4 aut | |
700 | 1 | |a Hoffmeister, Henrik |e verfasserin |4 aut | |
700 | 1 | |a Schneeberg, Pia |e verfasserin |4 aut | |
700 | 1 | |a Prause, Andre |e verfasserin |4 aut | |
700 | 1 | |a Lippmann, Petra |e verfasserin |4 aut | |
700 | 1 | |a Kusi-Nimarko, Josephine |e verfasserin |4 aut | |
700 | 1 | |a Hassell-Hart, Storm |e verfasserin |4 aut | |
700 | 1 | |a McGown, Andrew |e verfasserin |4 aut | |
700 | 1 | |a Guest, Daniel |e verfasserin |4 aut | |
700 | 1 | |a Lin, Yan |e verfasserin |4 aut | |
700 | 1 | |a Notaro, Anna |e verfasserin |4 aut | |
700 | 1 | |a Vinck, Robin |e verfasserin |4 aut | |
700 | 1 | |a Karges, Johannes |e verfasserin |4 aut | |
700 | 1 | |a Cariou, Kevin |e verfasserin |4 aut | |
700 | 1 | |a Peng, Kun |e verfasserin |4 aut | |
700 | 1 | |a Qin, Xue |e verfasserin |4 aut | |
700 | 1 | |a Wang, Xing |e verfasserin |4 aut | |
700 | 1 | |a Skiba, Joanna |e verfasserin |4 aut | |
700 | 1 | |a Szczupak, Łukasz |e verfasserin |4 aut | |
700 | 1 | |a Kowalski, Konrad |e verfasserin |4 aut | |
700 | 1 | |a Schatzschneider, Ulrich |e verfasserin |4 aut | |
700 | 1 | |a Hemmert, Catherine |e verfasserin |4 aut | |
700 | 1 | |a Gornitzka, Heinz |e verfasserin |4 aut | |
700 | 1 | |a Milaeva, Elena R |e verfasserin |4 aut | |
700 | 1 | |a Nazarov, Alexey A |e verfasserin |4 aut | |
700 | 1 | |a Gasser, Gilles |e verfasserin |4 aut | |
700 | 1 | |a Spencer, John |e verfasserin |4 aut | |
700 | 1 | |a Ronconi, Luca |e verfasserin |4 aut | |
700 | 1 | |a Kortz, Ulrich |e verfasserin |4 aut | |
700 | 1 | |a Cinatl, Jindrich |e verfasserin |4 aut | |
700 | 1 | |a Bojkova, Denisa |e verfasserin |4 aut | |
700 | 1 | |a Ott, Ingo |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Chemistry (Weinheim an der Bergstrasse, Germany) |d 1996 |g 27(2021), 71 vom: 20. Dez., Seite 17928-17940 |w (DE-627)NLM09455398X |x 1521-3765 |7 nnns |
773 | 1 | 8 | |g volume:27 |g year:2021 |g number:71 |g day:20 |g month:12 |g pages:17928-17940 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/chem.202103258 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 27 |j 2021 |e 71 |b 20 |c 12 |h 17928-17940 |